A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...
LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...
Earnings call Coherus Oncology doubled LOQTORZI sales to $40.8M in 2025 (113% YoY growth), achieved a 90%+ debt reduction, and completed its transformation into a focused oncology innovator.
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Researchers have found evidence of nuclear metabolic enzymes for the first time, contributing to our understanding of cancer ...
WACO, Texas - Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to ...
Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...
More than two hundred metabolic enzymes, many of which are normally tasked with producing energy in the mitochondria, are also found sitting directly on top of human DNA, according to a study ...